HVTN - redOrbit

News - HVTN

Inovio Pharmaceuticals Completes PENNVAX(TM)-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses

2011-09-14 03:00:00

BLUE BELL, Pa., Sept. 14, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.

Quintiles Transnational Corp. Announces Donation to Seattle Vaccine Research Fund

2006-03-21 12:01:00

WASHINGTON, March 21 /PRNewswire/ -- Quintiles Tr

More News (2 articles) »